| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2018 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEWS CORP NEW | 4 | Q3 2023 | 44.4% |
| NEWS CORP NEW | 4 | Q3 2023 | 20.5% |
| THERAVANCE BIOPHARMA INC | 4 | Q3 2023 | 10.3% |
| SOTERA HEALTH CO | 4 | Q3 2023 | 4.7% |
| BANDWIDTH INC | 4 | Q3 2023 | 3.8% |
| ARCONIC CORPORATION | 3 | Q2 2023 | 3.6% |
| BLACKLINE INC | 3 | Q3 2023 | 2.8% |
| DIGITAL RLTY TR INC | 3 | Q3 2023 | 2.5% |
| ISHARES TR RUSSELL 2000 ETF | 2 | Q1 2023 | 15.4% |
| ISHARES TR RUSSELL 2000 ETF | 2 | Q3 2023 | 10.5% |
View Irenic Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-26 |
| SC 13D/A | 2024-03-07 |
| SC 13D/A | 2024-02-28 |
| DFAN14A | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D | 2024-01-29 |
| SC 13D | 2023-12-20 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
View Irenic Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.